TF
TMO icon

Talbot Financial’s Thermo Fisher Scientific TMO Stock Holding History

Talbot Financial’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Buy
28,086
+883
+3% +$424K 1.04% 35
2026
Q1 		$13.4M Buy
27,203
+695
+3% +$377K 1.12% 35
2025
Q4 		$15.4M Buy
26,508
+121
+0.5% +$68.4K 1.26% 32
2025
Q3 		$12.8M Buy
26,387
+1,888
+8% +$879K 1.08% 36
2025
Q2 		$9.93M Buy
24,499
+7,097
+41% +$2.97M 0.94% 43
2025
Q1 		$8.66M Sell
17,402
-180
-1% -$97.5K 1.08% 36
2024
Q4 		$9.15M Buy
17,582
+1,062
+6% +$584K 1.09% 37
2024
Q3 		$10.2M Buy
16,520
+624
+4% +$369K 1.24% 33
2024
Q2 		$8.79M Buy
15,896
+415
+3% +$238K 1.13% 34
2024
Q1 		$9M Buy
15,481
+374
+2% +$210K 1.2% 33
2023
Q4 		$8.02M Buy
15,107
+1,488
+11% +$720K 1.21% 34
2023
Q3 		$6.89M Buy
13,619
+23
+0.2% +$12.3K 1.2% 35
2023
Q2 		$7.09M Buy
13,596
+407
+3% +$220K 1.21% 35
2023
Q1 		$7.6M Sell
13,189
-128
-1% -$72.1K 1.41% 30
2022
Q4 		$7.33M Buy
+13,317
New +$7.06M 1.51% 29

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Talbot Financial's TMO Position: Q2 2026 in Review

Talbot Financial increased its Thermo Fisher Scientific (TMO) stake by 3.2% in Q2 2026, buying an estimated $424K and bringing the position to 28,086 shares worth $14.1M. The position accounts for 1.04% of the portfolio, ranked #35.

Talbot Financial first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $15.4M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Talbot Financial held 28,086 shares of Thermo Fisher Scientific worth $14.1M as of Q2 2026.
  • Talbot Financial bought 883 Thermo Fisher Scientific shares in Q2 2026, an estimated $424K.
  • Thermo Fisher Scientific made up 1.04% of Talbot Financial's portfolio in Q2 2026, its #35 holding.
  • Talbot Financial first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Talbot Financial's Thermo Fisher Scientific position peaked at $15.4M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Talbot Financial's 13F filing for Q2 2026, filed 14 Jul 2026.